123 related articles for article (PubMed ID: 3286051)
1. Antidepressants in the treatment of post-psychotic depression in schizophrenia: drug interactions and other considerations.
Siris SG; Sellew AP; Frechen K; Cooper TB; Mandell J; Casey E
Clin Chem; 1988 May; 34(5):837-40. PubMed ID: 3286051
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 6- with 9-week trials of adjunctive imipramine in postpsychotic depression.
Siris SG; Adan F; Strahan A; Aronson A; Mandeli J; Fasano-Dube B
Compr Psychiatry; 1989; 30(6):483-8. PubMed ID: 2582754
[TBL] [Abstract][Full Text] [Related]
3. Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial.
Siris SG; Bermanzohn PC; Mason SE; Shuwall MA
Arch Gen Psychiatry; 1994 Feb; 51(2):109-15. PubMed ID: 7905256
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive imipramine for a broader group of post-psychotic depressions in schizophrenia.
Siris S; Pollack S; Bermanzohn P; Stronger R
Schizophr Res; 2000 Sep; 44(3):187-92. PubMed ID: 10962221
[TBL] [Abstract][Full Text] [Related]
5. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E
J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977
[TBL] [Abstract][Full Text] [Related]
6. Continuation and maintenance treatment trials of adjunctive imipramine therapy in patients with postpsychotic depression.
Siris SG; Strahan A
J Clin Psychiatry; 1988 Nov; 49(11):439-40. PubMed ID: 3182733
[TBL] [Abstract][Full Text] [Related]
7. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.
Siris SG; Morgan V; Fagerstrom R; Rifkin A; Cooper TB
Arch Gen Psychiatry; 1987 Jun; 44(6):533-9. PubMed ID: 3555386
[TBL] [Abstract][Full Text] [Related]
8. Comparative side effects of imipramine, benztropine, or their combination in patients receiving fluphenazine decanoate.
Siris SG; Rifkin A; Reardon GT; November M
Am J Psychiatry; 1983 Aug; 140(8):1069-71. PubMed ID: 6346910
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive imipramine maintenance treatment in schizophrenic patients with remitted postpsychotic depression.
Siris SG; Cutler J; Owen K; Mason S; Gingerich S; Lang MP
Am J Psychiatry; 1989 Nov; 146(11):1495-7. PubMed ID: 2817126
[TBL] [Abstract][Full Text] [Related]
10. Imipramine-responsive panic-like symptomatology in schizophrenia/schizoaffective disorder.
Siris SG; Aronson A; Sellew AP
Biol Psychiatry; 1989 Feb; 25(4):485-8. PubMed ID: 2649158
[No Abstract] [Full Text] [Related]
11. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap.
Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Casey E
Am J Psychiatry; 1988 Dec; 145(12):1532-7. PubMed ID: 3057924
[TBL] [Abstract][Full Text] [Related]
12. Ethopropazine and benztropine in neuroleptic-induced parkinsonism.
Chouinard G; Annable L; Ross-Chouinard A; Kropsky ML
J Clin Psychiatry; 1979 Mar; 40(3):147-52. PubMed ID: 33969
[TBL] [Abstract][Full Text] [Related]
13. Continuation treatment with adjunctive imipramine in schizophrenia.
Siris SG; Bermanzohn PC; Mason SE; Shuwall MA; Aseniero MA
Psychopharmacol Bull; 1992; 28(3):303-7. PubMed ID: 1480734
[TBL] [Abstract][Full Text] [Related]
14. Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate.
Siris SG; Cooper TB; Rifkin AE; Brenner R; Lieberman JA
Am J Psychiatry; 1982 Jan; 139(1):104-6. PubMed ID: 7055248
[No Abstract] [Full Text] [Related]
15. Targeted treatment of depression-like symptoms in schizophrenia.
Siris SG; Adan F; Cohen M; Mandeli J; Aronson A; Fasano-Dube B
Psychopharmacol Bull; 1987; 23(1):85-9. PubMed ID: 3602335
[No Abstract] [Full Text] [Related]
16. Adjunctive imipramine maintenance in post-psychotic depression/negative symptoms.
Siris SG; Mason SE; Bermanzohn PC; Alvir JM; McCorry TA
Psychopharmacol Bull; 1990; 26(1):91-4. PubMed ID: 2371372
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive imipramine for dysphoric schizophrenic patients with past histories of cannabis abuse.
Siris SG; Bermanzohn PC; Mason SE; Rifkin A; Alvir JM
Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jul; 16(4):539-47. PubMed ID: 1641497
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of impaired affect in recovering schizophrenic patients.
Hogarty GE; McEvoy JP; Ulrich RF; DiBarry AL; Bartone P; Cooley S; Hammill K; Carter M; Munetz MR; Perel J
Arch Gen Psychiatry; 1995 Jan; 52(1):29. PubMed ID: 7811160
[TBL] [Abstract][Full Text] [Related]
19. Extrapyramidal side effects in chlorpromazine recipients: emergence according to benztropine prophylaxis.
Swett C; Cole JO; Shapiro S; Slone D
Arch Gen Psychiatry; 1977 Aug; 34(8):942-3. PubMed ID: 889418
[TBL] [Abstract][Full Text] [Related]
20. Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression.
Siris SG; Frechen K; Strahan A; Cutler J; Owen K; Alvir J; McCorry T
Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(3):369-78. PubMed ID: 1907379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
